Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: Need for additional infection prevention strategies?

International Urology and Nephrology

Volumn 46, Issue 2, 2014, Pages 309-315

  Gopal Rao, G ^a   Batura, Deepak ^a  

^a EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Complications; Healthcare associated infections; Hospital readmissions; Length of stay; Prostate biopsy; Prostate cancer

Indexed keywords

AMIKACIN; CIPROFLOXACIN;

ADULT; AGED; ARTICLE; EMERGENCY CARE; ESCHERICHIA COLI; HOSPITAL ADMISSION; HUMAN; INFECTION COMPLICATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MICROBIOLOGY TEST; MIDDLE AGED; NONHUMAN; PROPHYLAXIS; PROSTATE BIOPSY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY; URINE RETENTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CIPROFLOXACIN; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; EMERGENCIES; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INCIDENCE; LENGTH OF STAY; LONDON; MALE; MIDDLE AGED; PATIENT ADMISSION; PROSTATE; RECTUM; RETROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY RETENTION;

EID: 84896721759     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0529-5     Document Type: Article

References (31)

1. Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, Loblaw DA, Trachtenberg J, Stanimirovic A, Simor AE, Seth A, Urbach DR, Narod SA (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963-968
2. Zlotta AR, Nam RK (2012) To biopsy or not to biopsy - thou shall think twice. Eur Urol 61:1115-1117
3. Loeb S, van Den HS, Zhu X, Bangma CH, Schroder FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61:1110-1114
4. Wagenlehner FM, Van OE, Tenke P, Tandogdu Z, Cek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE (2012) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63:521-527
5. Batura D, Gopal Rao G (2013) The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention. J Antimicrob Chemother 68:247-249
6. Patel U, Dasgupta P, Amoroso P, Challacombe B, Pilcher J, Kirby R (2012) Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int 109:1781-1785
7. Ganeswaran D, Sweeney C, Yousif F, Lang S, Goodman C, Nabi G (2012) Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer. World J Urol (Epub ahead of print). doi:10.1007/s00345-012-0893-2
8. Livermore DM, James D, Reacher M, Graham C, Nichols T, Stephens P, Johnson AP, George RC (2002) Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis 8:473-478 (Pubitemid 34533323)
9. Batura D, Gopal Rao G, Nielsen PB (2010) Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int 106:1017-1020
10. Andrews JM (2009) BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 64:454-489
11. Livermore DM, Hawkey PM (2005) CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 56:451-454 (Pubitemid 41264119)
12. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald W (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 136(5 Suppl):e28
13. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186:1830-1834
14. Sanders A, Buchan N (2013) Infection-related hospital admissions after transrectal biopsy of the prostate. ANZ J Surg 83:246-248
15. Rajgopal R, Wang Y, Faber KJ, Izawa JI (2012) Vertebral osteomyelitis following transrectal ultrasound-guided biopsy of the prostate. Can Urol Assoc J 6:E20-E22
16. Williamson DA, Roberts SA, Paterson DL, Sidjabat H, Silvey A, Masters J, Rice M, Freeman JT (2012) Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin Infect Dis 54: 1406-1412
17. Rogers BR, Batura D, Gopal Rao G (2013) Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: our experience in North West London. Clin Infect Dis 56:465-466
18. Hernandez-Graulau JM (2009) Editorial comment. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Urology 74:338-339
19. Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy-should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18:575-581
20. Liss MA, Peeples AN, Peterson EM (2011) Detection of fluoroquinolone- resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy. J Clin Microbiol 49:1116-1118
21. Batura D, Gopal Rao G, Nielsen PB, Charlett A (2011) Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int 107:760-764
22. Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan Y (2013) Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol 189:535-540
23. Ho HS, Ng LG, Tan YH, Yeo M, Cheng CW (2009) Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy. Ann Acad Med Singap 38:212-216
24. Goto T, Makinose S, Ohi Y, Yamauchi D, Kayajima T, Nagayama K, Hayami H (1998) Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate. Int J Urol 5:243-246 (Pubitemid 28302453)
25. Briffau R, Coloby P, Bruyere F, Ouaki F, Pires C, Dore B, Irani J (2009) One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy. BJU Int 103:1069-1073
26. Hori S, Sengupta A, Joannides A, Balogun-Ojuri B, Tilley R, McLoughlin J (2010) Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk? BJU Int 106:1298-1302
27. Bradley LA, Palomaki GE, Gutman S Samson D, Aronson N (2013) Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer. J Urol (Epub ahead of print). doi:10.1016/j.juro.2013.02.005
28. Helfand BT, Loeb S, Hu Q, Cooper PR, Roehl KA, McGuire BB, Baumann NA, Catalona WJ (2013) Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies. J Urol 189:1697-1701
29. Portalez D, Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M, Malavaud B (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62:986-996
30. Kirby R, Fitzpatrick JM (2012) Optimising repeat prostate biopsy decisions and procedures. BJU Int 109:1750-1754
31. Lorber G, Duvdevani M, Friedman M, Lavy E, Landau EH, Gofrit ON, Pode D, Steinberg D (2013) Sustained-release anti-bacterial varnish-coated biopsy needle for reduction of infection rates following prostate biopsy-in vitro model. J Endourol 27:277-283